Lissy de Ridder

Lissy de Ridder is a researcher in the Department of Pediatrics at Erasmus MC, Faculty of Medicine. Her work is centered on pediatric inflammatory bowel disease (IBD), with a strong focus on Crohn’s disease, transitional care, and immunological mechanisms underlying disease severity.

Her research interests span Inflammatory Bowel Disease, Pediatric Gastroenterology, Mucosal Immunology, and Transitional Care. She investigates patient-reported outcomes, mental health integration in chronic disease management, and the development of biomarkers for disease stratification and treatment response. Her work bridges clinical practice and immunological research to improve long-term outcomes in children and adolescents with IBD.

The recent articles reflect a strong trend toward translational research, combining clinical data with deep immunophenotyping to define patient subgroups. There is a clear emphasis on personalized medicine, mental health screening, and transition success metrics in pediatric IBD care. The research spans immunology, gastroenterology, and public health, indicating a multidisciplinary approach.

Scientific contributions and collaborations:

• Active in the Dutch Initiative on Crohn’s and Colitis (ICC)
• Member of Collaborative Paediatric IBD Research in the Netherlands
• Part of the Dutch Nurses Network Inflammatory Bowel Disease (NIBD)
• Involved in multi-center studies on transition care and immunotyping

She has supervised at least 5 academic works, indicating an active role in mentoring. Her research is supported by collaborative networks rather than individual grants mentioned. She contributes to high-impact journals in gastroenterology and immunology.

Dr. de Ridder is involved in research teams focused on pediatric IBD immunology and transitional care, working closely with clinicians and immunologists at Erasmus MC and national consortia to develop tools for monitoring and improving patient outcomes.